The Journal of pediatrics
-
The Journal of pediatrics · Sep 2007
Randomized Controlled Trial Multicenter StudyNebulized hypertonic saline in the treatment of viral bronchiolitis in infants.
To investigate the use of nebulized 3% hypertonic saline (HS) for treating viral bronchiolitis in moderately ill hospitalized infants by a prospective, randomized, double-blinded, controlled, multicenter trial. ⋯ The use of nebulized 3% HS is a safe, inexpensive, and effective treatment for infants hospitalized with moderately severe viral bronchiolitis.